Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
NCT05983432
This study is recruiting at 22 US sites in 15 states, according to its ClinicalTrials.gov record last updated .
Summary
The objective of this study is to evaluate the safety, tolerability, and efficacy of BL-B01D1 in patients with Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Non Small Cell Lung Cancer
- Esophageal Cancer
- Small Cell Lung Cancer
- Nasopharyngeal Cancer
- Head and Neck Squamous Cell Carcinoma
- Prostate Adenocarcinoma
- Ovarian Cancer
- Endometrial Cancer
- Cervical Cancer
- Triple Negative Breast Cancer
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- SystImmune Inc.
- Last updated on ClinicalTrials.gov
- September 21, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 4
- Beverly Hills Cancer Center · Beverly Hills, CA
- City of Hope Cancer Center · Duarte, CA
- University of California Irvine Medical Center · Orange, CA
- UCLA Santa Monica · Santa Monica, CA
Colorado · 1
- University of Colorado Cancer Center · Aurora, CO
Connecticut · 1
- Yale University, Yale Cancer Center · New Haven, CT
District of Columbia · 1
- Georgetown University Medical Center · Washington D.C., DC
Florida · 3
- Sylvester Comprehensive Cancer Center · Miami, FL
- Sara Cannon Research Institute Lake Nona · Orlando, FL
- Hematology - Oncology Associates of the Treasure Coast · Port Saint Lucie, FL
Illinois · 1
- Northwestern University Feinberg School of Medicine · Chicago, IL
Iowa · 1
- University of Iowa Hospital and Clinics · Iowa City, IA
Kentucky · 1
- Norton Cancer Institute · Louisville, KY
Massachusetts · 2
- Dana-Farber Cancer Institute · Boston, MA
- Massachusetts General Hospital · Boston, MA
New York · 1
- Memorial Sloan Kettering Cancer Center Head Neck Services · New York, NY
South Carolina · 1
- PRISMA Health/ITOR · Greenville, SC
Tennessee · 1
- Sarah Cannon - Tennessee Oncology · Nashville, TN
Texas · 2
- Oncology Consultants, P.A. · Houston, TX
- University of Texas M.D. Anderson Cancer Center · Houston, TX
Virginia · 1
- Virginia Cancer Specialists · Fairfax, VA
Washington · 1
- University of Washington Fred Hutchinson · Seattle, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.